Search results
Results From The WOW.Com Content Network
The Sysmex XE-2100 is a haematology automated analyser, used to quickly perform full blood counts and reticulocyte counts. It is made by the Sysmex Corporation. It can be run on its own, or connected to a blood film making and staining unit. Racks of blood go in on a tray on the right, and come out the left side.
Sysmex Corporation (シスメックス株式会社, Shisumekkusu Kabushiki-gaisha) is a Japanese company headquartered in Kobe that is engaged in the health care business. Originally called TOA Medical Electronics (a branch of the TOA Corporation ), the Sysmex brand was established in 1978, and were mainly involved with haematology analysers.
Quality control (QC) is a measure of precision, or how well the measurement system reproduces the same result over time and under varying operating conditions. Laboratory quality control material is usually run at the beginning of each shift, after an instrument is serviced, when reagent lots are changed, after equipment calibration, and ...
A package insert from 1970, with Ovrette brand contraception pills A package insert is a document included in the package of a medication that provides information about that drug and its use. For prescription medications , the insert is technical , providing information for medical professionals about how to prescribe the drug.
Quality control begins with sample collection and ends with the reporting of data. [4] AQC is achieved through laboratory control of analytical performance. Initial control of the complete system can be achieved through specification of laboratory services, instrumentation, glassware, reagents, solvents, and gases.
A quality control system (QCS) refers to a system used to measure and control the quality of moving sheet processes on-line as in the paper produced by a paper machine. Generally, a control system is concerned with measurement and control of one or multiple properties in time in a single dimension.
Process analytical technology (PAT) has been defined by the United States Food and Drug Administration (FDA) as a mechanism to design, analyze, and control pharmaceutical manufacturing processes through the measurement of critical process parameters (CPP) which affect the critical quality attributes (CQA).
In the pharmaceutical industry, drug dissolution testing is routinely used to provide critical in vitro drug release information for both quality control purposes, i.e., to assess batch-to-batch consistency of solid oral dosage forms such as tablets, and drug development, i.e., to predict in vivo drug release profiles. [1]